Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders
2 other identifiers
interventional
83
1 country
2
Brief Summary
Most people with an eating disorder (ED) do not receive good treatment. The investigators have developed a new brief group treatment that is supposed to work by reducing how much women with an ED value the impossible thinness standard promoted by the media and how much they value/crave binge foods. The investigators want to test whether the treatment actually changes those two mechanisms using brain scan data, which is more objective than completing questionnaires and even interviews. In the first phase of the study (R61), the investigators will compare women in the treatment versus those on a wait-list. If the investigators can show that the treatment "works" (does what the investigators think it does) compared to no active treatment (women will be allowed to seek and receive outside help but investigators will not provide it until after the wait-list), investigators will conduct the second phase of study (R33),where they will randomly assign women with an ED to either the new treatment or to a group treatment that represents what many college mental health clinics provide to their clients with ED.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2017
CompletedFirst Submitted
Initial submission to the registry
August 17, 2017
CompletedFirst Posted
Study publicly available on registry
August 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedJune 11, 2025
June 1, 2025
7.5 years
August 17, 2017
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in occurrences of binge eating episodes using Eating Disorder Diagnostic Interview
Interviewer assesses frequency in binge eating episodes
Week 8; R33 also reviews at 6-month follow-up
Change in occurrences of compensatory weight control behavior using Eating Disorder Diagnostic Interview
Interviewer assesses frequency of compensatory weight control behaviors
Week 8; R33 also reviews at 6-month follow-up
Change in psychosocial impairment due to eating disorder symptoms using the Clinical Impairment Assessment Questionnaire
Interviewer assesses change in psychosocial impairment
Week 8; R33 also reviews at 6-month follow-up
Secondary Outcomes (8)
Change in reward region of the brain using fMRI
Week 1 and Week 8
Change in suicidal ideation/attempts using the Patient Health Questionnaire version 9 (PHQ-9)
Weeks 2, 4 and 6
Change in negative affect using the Positive Affect and Negative Affect Scale-Revised
Weeks 2, 4, and 6
Change in body dissatisfaction using the Body Dissatisfaction Scale
Weeks 2, 4 and 6
Change in food addiction using the Yale Food Addiction Scale version 2.0
Weeks 2, 4, and 6
- +3 more secondary outcomes
Study Arms (2)
Body Project Treatment
EXPERIMENTALAn 8-session group-delivered eating disorder treatment that seeks to reduce valuation of the thin ideal and eating disordered behaviors used to pursue this ideal.
Interpersonal Psychotherapy
ACTIVE COMPARATORAn 8-session group-delivered eating disorder treatment that seeks to improve interpersonal functioning because this is theorized to maintain eating pathology.
Interventions
8 weekly 60 minute sessions of dissonance-based treatment wherein women with any eating disorder complete verbal, written, and behavioral activities.
8 weekly 60 minute sessions of interpersonal-based treatment wherein women with an eating disorder complete verbal, written, and behavioral activities.
Eligibility Criteria
You may qualify if:
- DSM-5 eating disorder
- Must have a primary care doctor
You may not qualify if:
- Non-English speakers
- BMI \<75% ideal body weight
- Current acute suicidal ideation (defined as thoughts of a specific method or plan)
- Comorbid psychiatric disorder that would disrupt groups (e.g., bipolar disorder, substance misuse)
- Serious medical problems (e.g., diabetes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (2)
Stanford University
Stanford, California, 94305, United States
Oregon Research Institute
Eugene, Oregon, 97403, United States
Related Publications (4)
Stice E, Yokum S, Rohde P, Shaw H, Gau JM, Johnson S, Johns A. Randomized trial of a dissonance-based transdiagnostic group treatment for eating disorders: An evaluation of target engagement. J Consult Clin Psychol. 2019 Sep;87(9):772-786. doi: 10.1037/ccp0000430.
PMID: 31403814RESULTStice E, Yokum S, Rohde P, Gau J, Shaw H. Evidence that a novel transdiagnostic eating disorder treatment reduces reward region response to the thin beauty ideal and high-calorie binge foods. Psychol Med. 2023 Apr;53(6):2252-2262. doi: 10.1017/S0033291721004049. Epub 2021 Oct 12.
PMID: 34635191RESULTStice E, Yokum S. Elevated reward, emotion, and memory region response to thin models predicts eating disorder symptom persistence: A prospective functional magnetic resonance imaging study. J Psychopathol Clin Sci. 2023 Aug;132(6):716-724. doi: 10.1037/abn0000843.
PMID: 37486363DERIVEDYokum S, Bohon C, Berkman E, Stice E. Test-retest reliability of functional MRI food receipt, anticipated receipt, and picture tasks. Am J Clin Nutr. 2021 Aug 2;114(2):764-779. doi: 10.1093/ajcn/nqab096.
PMID: 33851199DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Stice, PhD
Oregon Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry and Behavioral Sciences
Study Record Dates
First Submitted
August 17, 2017
First Posted
August 24, 2017
Study Start
July 10, 2017
Primary Completion
January 24, 2025
Study Completion
January 31, 2025
Last Updated
June 11, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- Descriptive/raw data will be submitted while the study is ongoing (every 6 months). Analyzed data will be submitted either when results are published or after the completion of the award period, whichever comes first.
Study data will be shared via the National Database for Clinical Trials Related to Mental Illness (NDCT), which is part of the NIMH Data Archive (NDA). All data, with the exception of video recordings of the participants in treatment, will be provided.